top of page
Browse by category
Search


Mazdutide anti-obesity drug achieves 11.7% body weight loss at 12-weeks
Innovent Biologics has announced that the results of a phase 1b study of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and...


Innovent starts Phase 2 Clinical Trial of mazdutide in Chinese adults with obesity
Innovent Biologics has announced that the first participant has been successfully dosed in the higher-dose cohort of a phase 2 clinical...
Browse by tag






bottom of page